Anti-angiogenesis therapy overcomes the innate resistance to PD-1/PD-L1 blockade in VEGFA-overexpressed mouse tumor models
Qiaohong Wang, Jingze Gao, Wen Di, Xia Wu
Topics & Concepts
AngiogenesisVascular endothelial growth factor ACancer researchTumor microenvironmentInnate immune systemBiologyImmune systemImmunologyMedicineVascular endothelial growth factorVEGF receptorsCancer Immunotherapy and BiomarkersImmune cells in cancerCancer, Hypoxia, and Metabolism